PHIA Koninklijke Philips N.V.

Philips and Regional Medical Center announce USD 16 million, long-term strategic partnership to innovate patient care for residents of rural South Carolina

Philips and Regional Medical Center announce USD 16 million, long-term strategic partnership to innovate patient care for residents of rural South Carolina

December 10, 2019

Partnership gives community health system access to same innovative Philips diagnostic imaging solutions of larger networks, bringing quality care closer to home and delivering on the Quadruple Aim

Amsterdam, the Netherlands and Orangeburg, United States – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the Regional Medical Center (RMC), today announced a strategic 5-year partnership agreement worth USD 16 million to deliver innovative diagnostic imaging solutions for the residents of rural Orangeburg, Calhoun, Bamberg and Barnwell counties in South Carolina, United States. The partnership will also support the expansion of the region’s only stand-alone community hospital, help RMC to standardize its imaging platforms and better integrate workflows and information, allowing for a better view of the patient. As a result, RMC will be better equipped to deliver on the Quadruple Aim: better outcomes, increased efficiency and improved patient and staff experience.

An hour outside of Charleston and 45 minutes from Columbia, RMC is the only acute care provider in the area, serving patients across a roughly 2,400-square-mile region of South Carolina. The healthcare system includes a 286-bed acute care hospital (designated as a Level III Trauma Center), and 24 primary and specialty care practices in Orangeburg, Calhoun, Bamberg and Barnwell counties. Regional Medical Center recently completed construction of a new USD 8.6 million emergency care facility in the city of Denmark in South Carolina. The 20,500-square-foot RMC Bamberg/Barnwell Emergency Medical Center provides round-the-clock emergency care, including diagnostic imaging, laboratory, observation and emergency transport services.

Long-term strategic partnerships (LSPs) are a growing trend used within hospitals and health systems to better manage the cost and complexity of their technology investments over a defined period of time, while expanding quality access to advanced medical care in order to improve patient outcomes. Philips is a leader in LSPs and the partnership will provide RMC with access to the latest diagnostic imaging solutions, such as the , which can help improve first-time- right diagnosis and perform faster exams. Moreover, RMC will have access to industry-leading minimally invasive solutions such as the . Azurion offers a unique operating system that optimizes integration and an intuitive user interface that puts controls at the clinician’s fingertips.

“Delivering truly outstanding care requires our clinical teams to be at the forefront of the latest developments in medicine. Partnering with a health tech leader like Philips ensures our early and ongoing access to leading-edge solutions that can help us deliver the high quality care our communities deserve,” said Charles Williams, President and CEO of Regional Medical Center. “Having access to quality imaging solutions is key to getting to a faster diagnosis and treatment, which will enable us to continue to expand care and ultimately improve patient outcomes.”

Through Philips Medical Capital’s flexible finance plan, long-term strategic partnerships also provide a predictable and stable financial model, while helping take the guesswork out of technology adoption. Its partnership with Philips will allow RMC to not only offer state-of-the-art technology and standardize its diagnostic imaging, but also better integrate imaging data, allowing clinicians to get access to the right patient data for better diagnosis and treatment.

“At Philips, we understand that delivering on the Quadruple Aim is a challenge for all health systems, regardless of size or location,” said Vitor Rocha, Chief Market Leader of Philips North America. “With 1 in 5 Americans living in rural areas, it is important that we work with health systems like Regional Medical Center to bring innovative care closer to home for the communities they serve. Together, we can ensure that patients in more rural counties get the same access to quality care as their big city neighbors.”  

For more information about the Regional Medical Center, visit .

For further information, please contact:

Joost Maltha

Philips Global Press Office

Tel.:

E-mail:

Twitter: @joostmaltha

Silvie Casanova



Philips North America



Tel:

E-mail:

Delandous Haynes

Regional Medical Center

Tel:

E-mail:

About Royal Philips

(NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

About Regional Medical Center

Owned by Orangeburg and Calhoun counties, Regional Medical Center (RMC) health care system includes a 286-bed, acute-care hospital certified by The Joint Commission and 24 primary care and specialty care practices. RMC also operates a new, 20,500-square foot emergency care facility serving Bamberg, Barnwell and surrounding areas. RMC has advanced certification as a Primary Stroke Center by The Joint Commission and is designated as a Level III Trauma Center by the South Carolina Department of Health and Environmental Control (DHEC).

 

Attachments

EN
10/12/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...

 PRESS RELEASE

Philips reiterates timing of 2026 outlook

Philips reiterates timing of 2026 outlook December 4, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales growth to accelerate sequentially in 2026 towards mid-single-digit gro...

 PRESS RELEASE

Philips expands commercial availability of world’s first real-time AI-...

Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy December 1, 2025 Commercial availability expanded across Europe and the United StatesReal-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular proceduresLumiGuide seamlessly integrates with Azurion, Philips’ proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Netherlands and Chicago, USA – (NYSE: PHG, AEX: PH...

 PRESS RELEASE

Philips launches Verida, world’s first detector-based spectral CT powe...

Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands and Chicago, USA – At RSNA 2025, (NYSE: PHG, AEX: PHIA), a global leader in health techno...

 PRESS RELEASE

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MR...

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled BlueSeal Horizon [1], an entirely new 3.0T MRI innovation platform that includes the industry’s first helium-free 3.0T magnet at . A pivotal advance in MRI innovation, helium-free [2] 3.0T is a major scientific achievement set to have s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch